Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.
about
Mendelian Randomisation Study of Childhood BMI and Early MenarcheEvacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressureSafety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trialPolymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health StudyIntegrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease riskGenetics of lipid traits and relationship to coronary artery diseasePrevention of fatal hepatic complication in schistosomiasis by inhibition of CETPTreatment of dyslipidemiaNew Era of Lipid-Lowering DrugsUnique features of high-density lipoproteins in the Japanese: in population and in genetic factorsTriglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studiesJTT-705: is there still future for a CETP inhibitor after torcetrapib?Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyAnacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionGenetic variants in CETP increase risk of intracerebral hemorrhage.Polymorphisms of genes involved in lipid metabolism and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study.Association of repeatedly measured intermediate risk factors for complex diseases with high dimensional SNP data.Nutrigenomics in cardiovascular medicine.Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms.Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitmCholesteryl ester transfer protein gene polymorphisms and longevity syndromeRationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomographyUpdate in new medications for primary care.Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and EAssociation of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.Association between Six CETP Polymorphisms and Metabolic Syndrome in Uyghur Adults from Xinjiang, China.Cholesteryl ester transfer protein (CETP) genotype and reduced CETP levels associated with decreased prevalence of hypertension.The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean populationAssociation of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.CETP inhibitors and cardiovascular disease: Time to think again.Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementCholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.Low cholesteryl ester transfer protein and phospholipid transfer protein activities are the factors making tree shrew and beijing duck resistant to atherosclerosisCholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics.CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese populationHigh-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity.
P2860
Q21296811-B1E56556-327C-41A5-948C-17DEB7EBB3EDQ24624286-DB44E6BD-2604-4A93-BF62-DC9D3E2EA9FFQ24648125-94A25F55-442B-46F3-85B4-6AA00D5900D4Q24649155-9B9E1D81-0EC2-48F6-A572-3D7C9FF3D8D3Q24656975-95F4672E-C83F-47B2-ADF5-B2DCAD177BD2Q26995252-36FB8D0C-B4B3-4B47-9165-4FC888F6D33AQ27011500-A7ED9E13-FF9B-4FDB-B750-29A9C973E6BDQ27026114-F4042A6D-A16B-4245-BD85-AEC04EFB0F73Q28072298-ADC5EDB5-CF40-4B27-9732-A67C1D460104Q28085611-F576FCC3-E0BD-4981-A72A-E71DC76E9A30Q28281855-04D91410-8B30-4062-A176-37239F907011Q28294797-A145FC59-93F5-4BE4-8C99-C57037B0459EQ29615729-17554473-AE44-4F14-B098-8EDB658D126FQ29999973-29A56AE2-4D4E-4CBD-AFE0-ABF85ED42939Q30275688-10628300-1415-4247-A541-642744514AA6Q30860042-123C18CF-45EB-4216-ABD8-511099C4F57CQ33537443-461500FD-CBAB-4B66-A30B-ADBAE767182FQ33605821-743CF055-0C7E-4BBB-A68B-EB4E55B3011AQ33612543-AFF76618-C340-4C9B-BD06-F5725216204BQ33639433-C5AEA5DE-DC1C-438C-9E00-CE293555327AQ33643426-1681D750-2EB4-468D-90C1-57C74AA6A6D0Q33699478-10701C77-A052-45FB-8070-19180502D8B5Q33719962-183F60F3-0C4C-4B4F-9364-0026EDD5558CQ33730845-DC07F05A-EF4A-4611-B626-E2E16926AAE7Q33754249-1A22BE69-8A9F-4EAC-85B5-7E03FBD535C6Q33835305-0C3BC1F3-BB61-47E3-910E-ED32842305D9Q33839977-ED5FE1BC-A01D-4B0F-BDD7-ED853E0BC151Q33884155-9762C762-69A7-4CCE-999E-20278A31952FQ33993233-C9B7D500-3BAC-49D2-BD83-5F20D8B1029FQ34053189-7FAB77B9-995E-4A45-910B-BA5E7AAAD45DQ34092398-402F7D58-FAD6-4213-B78D-0C5F551C0A21Q34109100-8069CC53-BB76-4C77-A107-0FD251B90651Q34149298-D265FB71-7D67-4D61-898F-672441984ACFQ34181381-0134B305-5B86-47F1-806F-A73940CC5932Q34243501-938C2DD3-0326-4AC8-A0DE-1308539E43A8Q34244120-65A3E267-488F-46B3-9AE7-48C938D886DBQ34253290-CE1EF5E4-4226-45EB-A64F-34DFBA0ADB99Q34441411-E13C893F-C5AD-4EA6-9FC9-79B5BC294BC7Q34455100-7600091E-04F3-4895-917E-500ABA4BD76EQ34493756-3B6FBB65-3DF2-4C7E-A52E-9DA18CDD9FA8
P2860
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of cholesteryl est ...... pid levels, and coronary risk.
@en
Association of cholesteryl est ...... pid levels, and coronary risk.
@nl
type
label
Association of cholesteryl est ...... pid levels, and coronary risk.
@en
Association of cholesteryl est ...... pid levels, and coronary risk.
@nl
prefLabel
Association of cholesteryl est ...... pid levels, and coronary risk.
@en
Association of cholesteryl est ...... pid levels, and coronary risk.
@nl
P2093
P356
P1476
Association of cholesteryl est ...... pid levels, and coronary risk.
@en
P2093
Alexander Thompson
Bernard Keavney
John Danesh
Nadeem Sarwar
Robin P F Dullaart
Sebhat Erqou
P304
P356
10.1001/JAMA.299.23.2777
P407
P577
2008-06-01T00:00:00Z